internal
Robert B. Ford
Chairman of the Board and Chief Executive Officer
Office of the CEO
9 yr
5 reports
Abbott Laboratories ·ABT
Four global business presidents run Abbott’s core P&Ls
Healthcare · Fortune #97 · Divisional structure · 114K employees · North Chicago, IL
5
CEO span
↓ tighter than peers (avg 10)
3.6
Avg span
moderate
2
Max depth
flat for 114K emp
4.8 yr
Avg tenure
80%
Internal hires
↑ above industry avg
Consolidated financials FY2025 · period end 2025-12-31 · 10-K
Revenue
$44.3B
Operating income
$8.1B
Net income
$6.5B
Total assets
$86.7B
Shares out
1.74B
Sourced from Abbott Laboratories DEF 14A · filed 2026-03-13 ↗ View on SEC
Interactive org chart
Abbott Laboratories organizational chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Open editable chart
Take this model into your AI workspace Use AI to reason through the model, then bring the scenario back into Creately Atlas.
Choose a prompt, then open an AI app and paste.
Download the CSV data instead
Four global business presidents report directly to Abbott’s CEO, giving the company a clean, P&L-driven divisional structure. This page maps Abbott’s executive team, analyzes reporting spans and tenure, and compares its leadership model with healthcare peers.
What to model
Use the chart to test org decisions, not just view reporting lines
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Latest signal Kevin Conroy joined as Director
Appointed to Abbott Board effective April 24, 2026.
Source · See change logScenario views in the chart
- Add Chief AI & Data Officer Creates a centralized AI and data role to coordinate analytics and digital health across divisions.
- Move Diabetes Care under Medical Devices Aligns Diabetes Care more closely with cardiovascular and device R&D for operational efficiency.
Atlas work this supports
- Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
- Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
- Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.
The people
Who's running this
6 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
internal
Lisa D. Earnhardt
Executive Vice President and Group President, Medical Devices
Medical Devices
4 yr
0 reports
internal
Philip P. Boudreau
Executive Vice President, Finance and Chief Financial Officer
Finance
3 yr
0 reports
internal
Daniel G. Salvadori
Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
Established Pharmaceuticals & Nutrition
6 yr
0 reports
Christopher J. Scoggins
Executive Vice President, Diabetes Care
Diabetes Care
2 yr
0 reports
internal
Elizabeth C. Cushman
Senior Vice President and Corporate Secretary
Legal & Governance
5 yr
0 reports
The pay
Executive compensation
From the most recent DEF 14A Summary Compensation Table. 1 named executive officers disclosed. Bar length scales with total compensation.
Robert B. Ford $24.2M
- Base salary
- $1.50M
- Stock awards
- $8.79M
- Option awards
- $8.79M
- Non-equity incentive
- $1.97M
- Pension change
- $2.19M
- Other
- $960K
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
The businesses
How Abbott Laboratories divides the work
3 divisions report into the group CEO. Tile size scales with estimated headcount.
Medical Devices
45K employees
EVP & Group President, Medical Devices (Lisa D. Earnhardt)
Designs and manufactures cardiovascular, neuromodulation, and diabetes-related devices worldwide.
Established Pharmaceuticals
30K employees
EVP & Group President, Established Pharmaceuticals (Daniel G. Salvadori)
Provides branded generics and therapeutics across emerging and developed markets.
Nutrition
20K employees
EVP & Group President, Nutrition (Daniel G. Salvadori)
Develops pediatric and adult nutritional products under brands like Similac and Ensure.
The thesis
Why this org is unusual
Abbott is distinctive in that four major operating businesses are each led by powerful group presidents with direct CEO access.
This divisional structure places full P&L accountability in Medical Devices, Established Pharmaceuticals & Nutritionals, and Diabetes Care, rather than centralizing control in a COO layer. The CEO’s span is moderate, but each division runs with significant autonomy.
Finance and governance functions remain centralized, while growth strategy and execution sit squarely with the business groups. This structure aligns with Abbott’s long-standing operating model following the AbbVie separation and subsequent portfolio expansion.
- No COO role
- Group presidents control P&Ls
- High internal promotion rate
The comparison
How Abbott Laboratories stacks up
Compared with peers like Medtronic and Johnson & Johnson, Abbott’s structure is more tightly divisional with fewer enterprise overlay roles. Unlike J&J, which has layered sector CEOs, Abbott keeps its business leaders one level below the CEO. Relative to GE Healthcare, Abbott shows greater internal promotion …
C-suite size
Reporting depth
Abbott Laboratories
2 levels
5 levels
Medtronic
5 levels
4 levels
GE Healthcare
4 levels
Avg C-suite tenure
Has COO / Has CAIO
Abbott Laboratories — no COO — no CAIO
Medtronic ✓ COO — no CAIO
GE Healthcare ✓ COO — no CAIO
Current signals
What changed recently
The most notable recent change was the retirement of long-time General Counsel Hubert Allen in mid‑2025.
- new
- departed
Leadership Timeline
Year-over-year executive structure based on SEC proxy and annual filings.
FY2025
DEF 14A filed 2026-03-13
- CEO
- Robert B. Ford
- CEO span
- 5
- C-suite
- 6
- Avg tenure
- 4.5 yr
Leadership centered on long-tenured CEO with stable divisional heads.
Named executive officers (5)
- Robert B. Ford - CEO since 2013
- Philip P. Boudreau - CFO since 2023
- Lisa D. Earnhardt - Group President, Medical Devices since 2021
- Daniel G. Salvadori - Group President, Established Pharma & Nutrition since 2019
- Christopher J. Scoggins - EVP, Diabetes Care since 2023
Frequently Asked Questions
Who is the CEO of Abbott Laboratories?
Robert B. Ford has served as Chairman and CEO of Abbott Laboratories since 2013.
What type of organizational structure does Abbott Laboratories use?
Abbott uses a divisional structure with major healthcare businesses led by group presidents.
How many direct reports does Abbott Laboratories's CEO have?
The CEO has five direct reports, primarily group presidents and the CFO.
How has Abbott Laboratories's leadership changed recently?
Recent changes include the retirement of long‑time General Counsel Hubert Allen in 2025 and the addition of a new board director in 2026.
Does Abbott Laboratories have a COO?
No. Abbott does not have a Chief Operating Officer; operations are led directly by business group presidents.
Sources
- 8-K Filing, Apr 27 2026
- DEF 14A, Mar 2026
- SEC EDGAR: Abbott Laboratories DEF 14A Proxy Statement
- SEC EDGAR: Abbott Laboratories 10-K Annual Report
Reference
Cite this page
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
APA 7th
Creately. (2026). Abbott Laboratories organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/abbott-laboratories/MLA 9th
"Abbott Laboratories Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/abbott-laboratories/. Accessed .Chicago 17
Creately. "Abbott Laboratories Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/abbott-laboratories/.Original SEC source View on SEC ↗
Abbott Laboratories. DEF 14A. Filed 2026-03-13. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1800/000130817926000064/abt-20260311.htmPermanent URL: https://creately.com/org-chart/fortune-500/abbott-laboratories/ · last updated 2026-04-01